Glutathione Sodium Medicine 03 June 2025 Extended indication Glutathione sodium monotherapy for preventive treatment of Myocardial injury in adults and elderly with pneumonia. Therapeutic value No estimate possible yet Total cost Registration phase Clinical trials Product Active substance Glutathione Sodium Domain Cardiovascular diseases Reason of inclusion New medicine (specialité) Main indication Other medication for cardiovascular diseases Extended indication Glutathione sodium monotherapy for preventive treatment of Myocardial injury in adults and elderly with pneumonia. Current proprietary name Already available biosimilars / generics Proprietary name Manufacturer Biomedica Foscama Portfolio holder Mechanism of action Route of administration Intravenous Therapeutical formulation Intravenous drip Budgetting framework Intermural (MSZ) Centre of expertise Additional remarks Registration Registration route Centralised (EMA) Type of trajectory Particularity ATMP No Submission date February 2026 Expected Registration March 2027 Orphan drug No Registration phase Clinical trials Reimbursement Medicine sluice Additional remarks Therapeutic value Current treatment options Statines, anti-hypertensie medicatie. Therapeutic value No estimate possible yet This assessment does not indicate any potential inclusion in the package. Substantiation Nog geen resultaten uit lopende studies gevonden. Duration of treatment Frequency of administration Dosage per administration References NCT06296212 Additional remarks Expected patient volume per year Patient volume Market share is generally not included unless otherwise stated. Maximum patient volume for sluice References 1:Expert opinie; Additional remarks Het is nog onduidelijk welke groep patiënten hiervoor in aanmerking komt. Dit is afhankelijk van aan welke groep patiënten dit geneesmiddel ingezet zal worden en hoe de behandelrichtlijn eruit zal zien. Expected cost per patient per year Cost References Additional remarks Potential total cost per year Total cost Total cost for sluice Additional remarks Off label use Off label use Indications off label use References Additional remarks Indication extension Indication extensions Indication extensions References Additional remarks Other information Additional remarks